RE-PHARM LIMITED
ROYSTON

Hellopages » Cambridgeshire » South Cambridgeshire » SG8 0SS

Company number 07447733
Status Active
Incorporation Date 23 November 2010
Company Type Private Limited Company
Address DR. ROBERT SCOFFIN, CRESSET BMD LTD, NEW CAMBRIDGE HOUSE BASSINGBOURN ROAD, LITLINGTON, ROYSTON, CAMBRIDGESHIRE, SG8 0SS
Home Country United Kingdom
Nature of Business 62020 - Information technology consultancy activities
Phone, email, etc

Since the company registration sixteen events have happened. The last three records are Confirmation statement made on 23 November 2016 with updates; Accounts for a dormant company made up to 30 November 2015; Annual return made up to 23 November 2015 with full list of shareholders Statement of capital on 2016-01-08 GBP 1 . The most likely internet sites of RE-PHARM LIMITED are www.repharm.co.uk, and www.re-pharm.co.uk. The predicted number of employees is 1 to 10. The company’s age is fourteen years and eleven months. Re Pharm Limited is a Private Limited Company. The company registration number is 07447733. Re Pharm Limited has been working since 23 November 2010. The present status of the company is Active. The registered address of Re Pharm Limited is Dr Robert Scoffin Cresset Bmd Ltd New Cambridge House Bassingbourn Road Litlington Royston Cambridgeshire Sg8 0ss. . SCOFFIN, Robert is a Secretary of the company. ROTHAUL, Alan Leslie, Dr is a Director of the company. SCOFFIN, Robert Arthur, Dr is a Director of the company. CRESSET BIOMOLECULAR DISCOVERY LTD is a Director of the company. Director BAXTER, Andrew Douglas, Dr has been resigned. The company operates in "Information technology consultancy activities".


Current Directors

Secretary
SCOFFIN, Robert
Appointed Date: 23 November 2010
Director
ROTHAUL, Alan Leslie, Dr
Appointed Date: 04 January 2011
70 years old
Director
SCOFFIN, Robert Arthur, Dr
Appointed Date: 23 November 2010
59 years old
Director
CRESSET BIOMOLECULAR DISCOVERY LTD
Appointed Date: 23 November 2010

Resigned Directors

Director
BAXTER, Andrew Douglas, Dr
Resigned: 08 May 2011
Appointed Date: 04 January 2011
61 years old

Persons With Significant Control

Cresset Biomolecular Discovery Limited
Notified on: 6 April 2016
Nature of control: Ownership of shares – 75% or more

RE-PHARM LIMITED Events

03 Jan 2017
Confirmation statement made on 23 November 2016 with updates
16 Sep 2016
Accounts for a dormant company made up to 30 November 2015
08 Jan 2016
Annual return made up to 23 November 2015 with full list of shareholders
Statement of capital on 2016-01-08
  • GBP 1
27 Nov 2014
Accounts for a dormant company made up to 27 November 2014
27 Nov 2014
Annual return made up to 23 November 2014 with full list of shareholders
Statement of capital on 2014-11-27
  • GBP 1
...
... and 6 more events
29 Nov 2011
Annual return made up to 23 November 2011 with full list of shareholders
09 Jul 2011
Termination of appointment of Andrew Baxter as a director
21 Jan 2011
Appointment of Dr Andrew Douglas Baxter as a director
21 Jan 2011
Appointment of Dr Alan Leslie Rothaul as a director
23 Nov 2010
Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Similar Companies

REPHA ENTERPRISE LIMITED REPHAEL HOUSE REPHGC LIMITED REPHIL LIMITED REPHINE LIMITED REPHINE SOURCING LTD REPHLEX NETWORKS LIMITED